Valuation Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 41.49 USD | -1.12% |
|
+3.98% | -5.81% |
Company Valuation: Scholar Rock Holding Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 872.1 | 467.6 | 1,356 | 4,046 | 4,493 | 5,053 | - | - |
| Change | - | -46.39% | 190.08% | 198.32% | 11.06% | 12.45% | - | - |
| Enterprise Value (EV) 1 | 709.3 | 414 | 1,304 | 3,918 | 4,270 | 4,736 | 4,642 | 4,663 |
| Change | - | -41.63% | 215.07% | 200.38% | 8.97% | 10.93% | -1.98% | 0.44% |
| P/E | -6.92x | -4x | -9.45x | -17.5x | -13.4x | -12.6x | -15.7x | -29.8x |
| PBR | 5.3x | 2.07x | 6.96x | 11x | 20.6x | 19.1x | 16.8x | 17.8x |
| PEG | - | 0.1x | 0.8x | -0.7x | -0.4x | -628.09x | 0.8x | 0.6x |
| Capitalization / Revenue | 46.3x | 14.1x | - | - | - | 890x | 35.7x | 13.2x |
| EV / Revenue | 37.7x | 12.5x | - | - | - | 835x | 32.8x | 12.1x |
| EV / EBITDA | -5.57x | - | - | - | -11.1x | -11x | -15x | -40.6x |
| EV / EBIT | -5.46x | -3.08x | -7.62x | -15.5x | -11.1x | -10.9x | -13x | -26.3x |
| EV / FCF | -5.37x | -3.1x | -8.98x | -19.5x | -14.2x | -17.1x | -21.2x | -55.3x |
| FCF Yield | -18.6% | -32.3% | -11.1% | -5.13% | -7.04% | -5.85% | -4.72% | -1.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.59 | -2.26 | -1.99 | -2.47 | -3.29 | -3.291 | -2.638 | -1.392 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18.82 | 33.19 | - | - | - | 5.674 | 141.7 | 384.2 |
| EBITDA 1 | -127.3 | - | - | - | -383 | -429.2 | -308.8 | -114.9 |
| EBIT 1 | -129.9 | -134.4 | -171.3 | -252.1 | -384.6 | -432.8 | -357.8 | -177.2 |
| Net income 1 | -131.8 | -134.5 | -165.8 | -246.3 | -377.9 | -427 | -358.2 | -194 |
| Net Debt 1 | -162.8 | -53.53 | -51.84 | -127.7 | -223.8 | -316.5 | -410.4 | -390 |
| Reference price 2 | 24.84 | 9.05 | 18.80 | 43.22 | 44.05 | 41.49 | 41.49 | 41.49 |
| Nbr of stocks (in thousands) | 35,108 | 51,663 | 72,143 | 93,615 | 102,007 | 121,785 | - | - |
| Announcement Date | 07/03/22 | 07/03/23 | 19/03/24 | 27/02/25 | 03/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.61x | 834.71x | -11.04x | -.--% | 5.05B | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 7.93x | 26.43x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 22.83x | 107.27x | 13.03x | 0.29% | 38.82B | |
| Weighted average by Cap. | 26.21x | 35.85x | 15.58x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SRRK Stock
- Valuation Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
